Safety and Efficacy of Reduced Dose of Enzalutamide in Patients with Castration-Resistant Prostate Cancer: A Systematic Review

<b>Objective:</b> To review the efficacy and safety of reduced dose compared to standard dose Enzalutamide treatment for patients with castration-resistant prostate cancer (CRPC). <b>Methods:</b> PubMed, Scopus, Web of Science, and Cochrane databases were searched for randomized controlled trials an...

पूर्ण विवरण

ग्रंथसूची विवरण

मुख्य लेखकों:	Zineddine Belabaci, Lucas Mose, Omar El-Taji, Zina Otmani, Zein Alabdin Hannouneh, Issa Mohamad, Thomas Zilli, Osama Mohamad, Nadeem Pervez, Waleed Arafat, Ursula Vogl, Mohamed Shelan
स्वरूप:	Artigo
भाषा:	Inglês
प्रकाशित:	MDPI AG 2025-05-01
श्रृंखला:	Pharmaceuticals
विषय:	castration-resistant prostate cancer enzalutamide dose efficacy adverse events
ऑनलाइन पहुंच:	https://www.mdpi.com/1424-8247/18/5/732
टैग:	टैग जोड़ें कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!